12-mm Partial Covered Versus Bare Self-Expandable Metallic Stents for Malignant Distal Biliary Obstruction

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorChung-Ang University Hospital

About this trial

Metallic stents are commonly used for biliary drainage in patients with unresectable malignant distal biliary obstruction. However, it is unclear whether a 12-mm partially covered self-expandable metallic stent or a 12-mm bare self-expandable metallic stent provides better effectiveness and safety. This prospective, randomized clinical trial will compare these two stent types in adult patients who have already undergone percutaneous transhepatic biliary drainage (PTBD) and are scheduled for metallic stent placement through the existing PTBD tract. A total of 60 participants will be enrolled. After stent placement, participants will be followed for 12 months, with assessments at 3, 6, and 12 months. The study will evaluate recurrent biliary obstruction, stent patency duration, reintervention, overall survival, and procedure-related complications. The results are expected to provide evidence for selecting the most appropriate 12-mm metallic stent for patients with unresectable malignant distal biliary obstruction.

Eligibility criteria

Qualifiers

Patients who voluntarily provide written informed consent after receiving sufficient explanation of the study purpose, methods, and potential benefits and risks

Adults aged 19 years or older

Patients diagnosed with unresectable malignant distal biliary obstruction based on imaging studies (CT, MRI, ERCP, etc.) or histologic confirmation

Patients who have already undergone percutaneous transhepatic biliary drainage (PTBD) according to the institutional clinical protocol and are scheduled for metallic stent placement through the existing PTBD tract

Disqualifiers

Patients with a previous history of biliary metallic stent placement

Patients with upper biliary obstruction (hilar level or above)

Patients with other major biliary lesions in addition to malignant distal biliary obstruction

Patients for whom the investigator judges that study conduct or data collection would be markedly difficult

Trial design

Treatments tested in this trial

  • 12-mm partially covered self-expandable metallic stent
  • 12-mm bare self-expandable metallic stent

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Chung-Ang University Hospital

Lead sponsor

OSYMED CO., Ltd.

Collaborator